Cytomegalovirus haemorrhagic colitis complicating COVID-19 in an immunocompetent critically ill patient: a case report

Running title

Cytomegalovirus haemorrhagic colitis and COVID-19

Authors

Sophie Leemans1 (SL), Evelyne Maillart1 (EM), Héloïse Van Noten1 (HVN), Lucas Oliveira Dos Santos2 (LODS), Laura Maria Leahu3 (LML), Prochore Kamgang2(PK), Andrea Gallerani4 (AG), Philippe Clevenbergh1(PC)

Authors affiliations

1Department of Infectious Diseases, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium
2Department of Internal Medicine, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium
3Department of Physical and Rehabilitation Medicine, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium
4Department of Intensive Care Medicine, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium

Authors contributions

All authors have made substantial contributions in acquisition of data and their interpretation.
SL wrote the draft, which was actively revised by PC, EM, HVN and PK.

Corresponding author

Sophie Leemans MD
Department of Infectious Diseases
CHU Brugmann, Place Van Gehuchten 4, 1020 Brussels, Belgium
Tel.: +32 2 477 36 68
E-mail:sophie.leemans@chu-brugmann.be
ORCID ID: 0000-0001-7331-5159

Disclosure of interest

The authors report no conflict of interest.

Funding

None.

Ethical approval

The authors confirm that the patient signed an informed consent document before the submission of this manuscript.
Cytomegalovirus haemorrhagic colitis complicating COVID-19 in an immunocompetent critically ill patient
Leemans S, Maillart E, Van Noten H, Oliveira Dos Santos L, Leahu LM, Kamgang P, Gallerani A and Clevenbergh P